Astellas Pharma ^Investors

Astellas Pharma is a global pharmaceutical research and development company that focuses on accelerating the discovery, development, and commercialization of innovative treatments for difficult-to-treat diseases. With a vision to be at the forefront of healthcare change, Astellas aims to turn innovative science into meaningful value for patients. The company operates in approximately 70 countries and has a workforce of around 14,000 employees. Astellas' core products include anticancer agents, treatments for overactive bladder and menopause symptoms, and immunosuppressants for organ transplantation. In its FY2022 financial results, Astellas achieved revenue of approximately 1,500 billion yen (around $11 billion) and invested about 280 billion yen (around $2.0 billion) in research and development.